«A common fallacy is that
schizophrenia can be treated as a single disease,» says NYU Langone psychiatrist and lead study author Dolores Malaspina, MD. «Our biologically driven study begins to answer longstanding questions in the field about
why any two people diagnosed with
schizophrenia may have drastically different
symptoms.